Draft Genome Sequence of a Bordetella pertussis Strain with the Virulence-Associated Allelic Variant ptxP3, Isolated

A Anselmo1, G Buttinelli2, A Ciammaruconi1

  • 1Army Medical and Veterinary Research Center, Rome, Italy.

Genome Announcements
|September 12, 2015
PubMed

Insights

Pertussis persists despite vaccination. This study sequenced a Bordetella pertussis strain carrying the ptxP3 variant, isolated from a critically ill infant, offering insights into pertussis resurgence.

Area of Science:

  • Microbiology
  • Genomics
  • Infectious Diseases

Background:

  • Pertussis (whooping cough) remains a significant public health concern, particularly for infants, despite widespread immunization efforts.
  • Resurgence of pertussis highlights the need to understand circulating strains and their genetic characteristics.
  • The virulence-associated allelic variant ptxP3 is frequently found in contemporary pertussis outbreaks.

Purpose of the Study:

  • To perform whole-genome sequencing of a Bordetella pertussis isolate.
  • To characterize a strain associated with severe infant pertussis, focusing on virulence factors.
  • To contribute genomic data for understanding pertussis epidemiology and vaccine effectiveness.

Main Methods:

  • Isolation of Bordetella pertussis from a clinical sample.
  • Whole-genome sequencing and bioinformatic analysis.
  • Identification of specific genetic variants, including the ptxP3 allele.

Main Results:

  • The complete genome sequence of the Bordetella pertussis strain was determined.
  • The isolate was confirmed to possess the ptxP3 allelic variant, a key virulence factor.
  • The strain was isolated from a 45-day-old infant, underscoring the risk to vulnerable populations.

Conclusions:

  • Genomic sequencing provides valuable data on circulating Bordetella pertussis strains.
  • The presence of the ptxP3 variant in an infant case warrants further investigation into its role in disease severity.
  • Understanding the genetic makeup of pertussis pathogens is crucial for public health strategies and vaccine development.